Disabled MicroConstants China Inc;Pertinax Therapeutics Inc
发明人:
Incledon, Beverly James,Lee, Yiu-Chung,Yang, Qicheng David
申请号：
AU2014383868
公开号：
AU2014383868A1
申请日:
2014.02.19
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
A method for treating various types of cancer/tumor by administering the combination of SDF-1 antagonist, in particular, that specifically binds to human CXCR4, and another chemotherapeutic agent, or a radiation therapy, during an embolization therapy. Such combination therapies exhibit synergistic effects compared to the treatment with either agent alone. Thus, the method is particularly beneficial for cancer patients who have low tolerance to the side effects caused by high dosages required for the treatment by either agent alone.
